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Background
Food-induced anaphylaxis is often a severe allergic reac-
tion characterized by multi-organ dysfunction and a
potentially fatal outcome, and accounts for one third to
one-half of anaphylactic reactions treated in emergency
departments worldwide. Presently, the role of specific
effector cells, immunoglobulins and other effector mole-
cules to food-induced anaphylaxis remains to be fully
elucidated.
Methods
To investigate the relative contribution of immunoglo-
bulin-dependent effector pathways to anaphylactic
responses to peanut, wild-type and various mutant mice
were sensitized with peanut protein and cholera toxin
via oral gavage, once weekly for four weeks. Mice were
subjected to different cellular depletion and Fc receptor
blocking strategies prior to intraperitoneal challenge
with peanut one week following the last sensitization. A
number of clinical, physiological and immunological
outcomes were evaluated.
Results
Our data indicate that pathways, other than the classical
mast cell-IgE pathway, contribute to the full spectrum
of anaphylactic reactions to peanut. We show that,
remarkably, the combined deficiency of mast cells and
macrophages, but not mast cells and basophils, or single
depletion of macrophages or basophils, averted nearly
all clinical and physiological signs of anaphylaxis. How-
ever, the single deletion of mast cells, basophils or
macrophages prevented the most significant clinical out-
come, death. Furthermore, our data show that using
IgE- and IgG1-deficient mice as well as FcRIII blockade,
both IgE and IgG1 signalling are necessary to fully
abolish anaphylactic responses to peanut. While mast
cell responses occurred via IgE and IgG1, macrophage
responses were fully mediated through IgG1.
Conclusions
Peanut-induced anaphylaxis is a process that involves
the concerted action of multiple immune effector path-
ways, and thus interventions targeting one single path-
way (e.g. mast cell/IgE) may not be sufficient to fully
prevent anaphylactic responses.
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